Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 4, 2016
Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infectionYuki Nakamura, Hiroshi Aikata, Takayuki Fukuhara, et al.
Journal of Gastroenterology|October 12, 2012
Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosisYuko Nagaoki, Hiroshi Aikata, Tomoki Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 29, 2011
Clinical outcome of esophageal varices after hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with major portal vein tumor thrombusHideaki Kodama, Hiroshi Aikata, Eisuke Murakami, et al.
Journal of Gastroenterology and Hepatology|December 11, 2012
Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinomaYohji Honda, Tomoki Kimura, Hiroshi Aikata, et al.
Journal of Gastroenterology and Hepatology|August 12, 2016
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patientsKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 26, 2017
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinomaYuji Teraoka, Tomoki Kimura, Hiroshi Aikata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 29, 2011
Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining regionTomokazu Kawaoka, Hiroshi Aikata, Daisuke Miyaki, et al.
BMC Gastroenterology|August 1, 2021
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year studyYuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2014
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis CYuko Nagaoki, Michio Imamura, Yoshiiku Kawakami, et al.
BMC Cancer|June 6, 2018
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trialMasahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, et al.
Pageof 7